Nexalin Technology Inc

NEW
NAS:NXL (USA)  
$ 2.16 -0.18 (-7.69%) 12:08 AM EST
At Loss
P/B:
7.71
Market Cap:
$ 28.74M
Enterprise V:
$ 28.19M
Volume:
126.56K
Avg Vol (2M):
265.70K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
126.56K
At Loss
Avg Vol (2M):
265.70K

Business Description

Nexalin Technology Inc
NAICS : 423450 SIC : 5047
ISIN : US65345B2016
Description
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.87
Interest Coverage No Debt
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.19
Distress
Grey
Safe
Beneish M-Score -6.32
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 36.64
9-Day RSI 40.41
14-Day RSI 41.21
3-1 Month Momentum % -8.42
6-1 Month Momentum % 277.59
12-1 Month Momentum % 400

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.24
Quick Ratio 6.92
Cash Ratio 6.36
Days Inventory 1597.89
Days Sales Outstanding 22.03
Days Payable 1464.06

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -39.5
Shareholder Yield % -15.57

Financials (Next Earnings Date:2025-05-30 Est.)

NXL's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NXL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Nexalin Technology Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.169
EPS (TTM) ($) -0.82
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % 456.25
14-Day RSI 41.21
14-Day ATR ($) 0.284726
20-Day SMA ($) 2.3505
12-1 Month Momentum % 400
52-Week Range ($) 0.5 - 4.4899
Shares Outstanding (Mil) 13.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nexalin Technology Inc Filings

Filing Date Document Date Form
No Filing Data

Nexalin Technology Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Nexalin Technology Inc Frequently Asked Questions

What is Nexalin Technology Inc(NXL)'s stock price today?
The current price of NXL is $2.16. The 52 week high of NXL is $4.49 and 52 week low is $0.50.
When is next earnings date of Nexalin Technology Inc(NXL)?
The next earnings date of Nexalin Technology Inc(NXL) is 2025-05-30 Est..
Does Nexalin Technology Inc(NXL) pay dividends? If so, how much?
Nexalin Technology Inc(NXL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1